Literature DB >> 11817522

Olanzapine-induced agranulocytosis: a case report and review of the literature.

Carles Tolosa-Vilella1, Ada Ruiz-Ripoll, Begoña Mari-Alfonso, Elsa Naval-Sendra.   

Abstract

The novel antipsychotic olanzapine has structural and pharmacological properties similar to clozapine. Until recently, no haematological toxicity has been reported with olanzapine use and it was expected to be a safer alternative. The authors report a case of agranulocytosis induced by olanzapine and reviewed the 11 cases reported in the literature.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11817522     DOI: 10.1016/s0278-5846(01)00258-5

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  2 in total

1.  Olanzapine and pancytopenia with severe folate deficiency.

Authors:  F Maurier; N Petitpain; J-F Guichard; L Javot; P Tréchot
Journal:  Eur J Clin Pharmacol       Date:  2010-02-06       Impact factor: 2.953

Review 2.  Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future.

Authors:  Peng Li; Gretchen L Snyder; Kimberly E Vanover
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.